نتایج جستجو برای: ucn

تعداد نتایج: 640  

Journal: :Endocrinology 2000
M J Bradbury M I McBurnie D A Denton K F Lee W W Vale

Intracerebroventricular injection of CRF or urocortin (Ucn) reduces appetite and body weight. CRFR1 and CRFR2, the receptors for CRF and Ucn, are expressed in neurons associated with appetite-control and metabolism, but their relative contributions in mediating CRF- or Ucn-induced hypophagia and weight loss are not known. We used homozygous mice lacking CRFR1 (CRFR1-/-) and wild-type littermate...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2007
Chien Li Peilin Chen Joan Vaughan Kuo-Fen Lee Wylie Vale

Urocortin 3 (Ucn 3), a member of the corticotropin-releasing factor (CRF) family of peptides, is strongly expressed in mammalian pancreatic beta cells and has been shown to stimulate insulin secretion. Here we report the investigation of the hypothesis that endogenous Ucn 3 regulates insulin secretion, particularly in the presence of nutrient excess. Secretion of Ucn 3-like immunoreactivity fro...

Journal: :Cancer research 1999
H Jiang L Y Yang

UCN-01, an anticancer agent currently in Phase I clinical trials, has been found to potentiate the cytotoxicity of cisplatin (CDDP). Because mammalian cells remove CDDP-induced DNA adducts through the nucleotide excision repair (NER) pathway, we determined the effects of UCN-01 on NER by measuring its effects on the interaction of the repair factors XPA and ERCC1 and the phosphorylation/dephosp...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2003
Ryan K Bachtell Adam Z Weitemier Agustin Galvan-Rosas Natalia O Tsivkovskaia Fred O Risinger Tamara J Phillips Nicholas J Grahame Andrey E Ryabinin

Identifying and characterizing brain regions regulating alcohol consumption is beneficial for understanding the mechanisms of alcoholism. To this aim, we first identified brain regions changing in expression of the inducible transcription factor c-Fos in the alcohol-preferring C57BL/6J (B6) and alcohol-avoiding DBA/2J (D2) mice after ethanol consumption. Drinking a 5% ethanol/10% sucrose soluti...

2003
Yun Dai Xin-Yan Pei Mohamed Rahmani Daniel H. Conrad Paul Dent

Interactions between pharmacologic NFB inhibitors (eg, Bay 11-7082, SN-50) and the checkpoint abrogator UCN-01 have been examined in human multiple myeloma (MM) cells. Exposure of U266 cells to Bay 11-7082 (Bay) in combination with UCN-01 resulted in the abrogation of NFB/DNA binding activity and the synergistic induction of apoptosis. Comparable synergism was observed in other MM cell lines an...

Journal: :American journal of physiology. Heart and circulatory physiology 2007
Paul A Townsend Sean M Davidson Samantha J Clarke Igor Khaliulin Christopher J Carroll Tiziano M Scarabelli Richard A Knight Anastasis Stephanou David S Latchman Andrew P Halestrap

Urocortin (UCN) protects hearts against ischemia and reperfusion injury whether given before ischemia or at reperfusion. Here we investigate the roles of PKC, reactive oxygen species, and the mitochondrial permeability transition pore (MPTP) in mediating these effects. In Langendorff-perfused rat hearts, acute UCN treatment improved hemodynamic recovery during reperfusion after 30 min of global...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2002
Chien Li Joan Vaughan Paul E Sawchenko Wylie W Vale

Urocortin (Ucn) III, or stresscopin, is a new member of the corticotropin-releasing factor (CRF) peptide family identified in mouse and human. Pharmacological studies showed that Ucn III is a high-affinity ligand for the type 2 CRF receptor (CRF-R2). To further understand physiological functions the peptide may serve in the brain, the distribution of Ucn III neurons and fibers was examined by i...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
P C Mack D R Gandara C Bowen M J Edelman T Paglieroni J B Schnier E P Gelmann P H Gumerlock

7-Hydroxystaurosporine (UCN-01), a protein kinase inhibitor in clinical development, demonstrates potent antineoplastic activity. To determine whether specific genetic abnormalities would modulate the response to UCN-01, a model of human non-small cell lung carcinoma (NSCLC) cell lines with differential abnormalities of p16CDKN2, RB, and p53 was used for these studies. Cell growth was measured ...

2005

anticancer drug that acts via inhibiting protein kinase C (PKC) and cyclin-dependent kinase 2 (CDK2). In pre-clinical studies, the compound exhibited potent anti-tumor effects both in vitro and in vivo. During clinical evaluation, the plasma concentrations of UCN-01 were much higher than predicted from non-clinical studies in experimental animals. The unexpectedly high plasma concentrations of ...

Journal: :Journal of the National Cancer Institute 1996
Q Wang S Fan A Eastman P J Worland E A Sausville P M O'Connor

BACKGROUND Arrest of the cell cycle in G2 phase following DNA damage helps protect cell viability by allowing time for DNA repair before entry into mitosis (M phase). Abrogation of G2 arrest sensitizes cells to the effects of DNA-damaging agents. UCN-01 (7-hydroxystaurosporine), a protein kinase C inhibitor that may block G2 checkpoint regulation, has been reported to enhance the cytotoxicity o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید